Vaasavaa Pharmaceuticals Private Limited, a active private limited company, was established on 17 July 2000 in Solapur, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232PN2000PTC015122. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.42 Cr.
It upholds a compliant status. Employing 67 professional, Its leadership includes Narasimha Rao Polavarapu (Director), Murali Krishna Prasad Koneru (Director), Sri Ram Dhanekula (Director). Past directors included Sri Ram Dhanekula. It holds ₹10.62 Cr open charges and ₹12.49 Cr settled loans. Its latest AGM occurred on 14 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No C-216 Midc Chincholiarea, Solapur, Maharashtra, 413255.
U24232PN2000PTC015122
015122
17 July 2000
₹1.50 Cr
₹1.42 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Vaasavaa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narasimha Rao Polavarapu | Director | 23 Jun 2003 | Current |
| Murali Krishna Prasad Koneru | Director | 17 Jul 2000 | Current |
| Sri Ram Dhanekula | Director | 04 Jul 2013 | Current |
| Subbarao Chandraskhar Rao Movva | Director | 17 Jul 2000 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vaasavaa Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 51.27% decrease. The company also saw a substantial fall in profitability, with a 79.93% decrease in profit. The company's net worth moved up by a moderate rise of 3.59%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Vaasavaa Pharmaceuticals had a public holding of 36.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹106,230,200.00
₹124,857,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Sep 2021 | Yes Bank Limited | ₹9.61 Cr | Open |
| 28 Feb 2021 | Others | ₹3.00 M | Open |
| 16 Jul 2020 | Others | ₹7.13 M | Open |
| 28 Mar 2019 | Others | ₹2.50 M | Satisfied |
| 07 Oct 2013 | Andhra Bank | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Vaasavaa Pharmaceuticals has a workforce of 67 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Vaasavaa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaasavaa Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Yes Bank Limited of Rs. 9.61 Cr registered on 23 Sep 2021 with Charge ID 100496530 was modified on 19 Sep 2025. was documented.
Vaasavaa Pharmaceuticals Private Limited last Annual general meeting of members was held on 14 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge registered on 28 Mar 2019 via Charge ID 100255617 with Others was fully satisfied on 13 May 2024. was completed.
Progress on Vaasavaa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
A charge registered on 07 Oct 2013 via Charge ID 10462868 with Andhra Bank was fully satisfied on 26 Nov 2021. was recorded as a recent event.
The activity A charge registered on 07 Nov 2007 via Charge ID 10077022 with Others was fully satisfied on 26 Nov 2021. was completed.
The CIN of Vaasavaa Pharmaceuticals Private Limited is U24232PN2000PTC015122.
Vaasavaa Pharmaceuticals Private Limited is headquartered at Plot No C-216 Midc Chincholiarea, Solapur, Maharashtra, 413255.
Vaasavaa Pharmaceuticals Private Limited was incorporated on 17 July 2000.
The current directors of Vaasavaa Pharmaceuticals Private Limited are
The primary industry of Vaasavaa Pharmaceuticals Private Limited is Manufacturing.
Vaasavaa Pharmaceuticals Private Limited is unlisted.
The authorized capital of Vaasavaa Pharmaceuticals Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.42 Cr.
The compliance status of Vaasavaa Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX